Research and Development

US science and tech development and commercialisation firm Allied Minds has appointed Kevin Sharer to its board of directors.  Sharer …

One year can make all the difference. The 2014 American Society of Clinical Oncology (ASCO) meeting took place just weeks …

Merck has launched the first new drug in a class of antibiotics in the UK in almost 15 years, becoming …

An FDA advisory panel has backed a new drug intended to boost female sex drive, but warned that it must …

inVentiv Health has appointed Michael McKelvey as the president of its health clinical division and executive vice president.  McKelvey is …

UK, Canterbury-based dermatology firm Creabilis has appointed Catherine Moukheibiras as the chairman of its board of directors. After an initial career in strategy …

Merck is continuing to investigate Keytruda combinations as it signs a deal to test the drug with an immunotherapy from …

Clark Health Communications (CHC) has announced the hire of three new team members. The UK, London-based firm has recently welcomed …

Corinne Le Goff is joining Amgen to be its senior vice president and head of the European region for the …

Bristol-Myers Squibb has presented data showing that a combination of its immunotherapies Opdivo and Yervoy significantly increases survival in advanced …

The Imperial Innovations Group has confirmed the appointment of Dr Paolo Paoletti to be the executive chairman of Kesios Therapeutics.Paoletti …

For pharma, the elevator pitch for 23andMe is an intriguing prospect. It has the largest genetic database in the world, …

A Phase III trial of Bristol-Myers Squibb’s immunotherapy Opdivo has found it increases overall survival in people with a common …

AstraZeneca and Eli Lilly are teaming up to run a clinical trial of two of the companies’ anti-cancer drugs. The …

UK’s Huntingdon Life Sciences and Harlan Laboratories has appointed Dr Joseph Bedford to serve as corporate vice president of global …